We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
-18.82%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$1.03B
AUM Growth
-$200M
Cap. Flow
+$16M
Cap. Flow %
1.55%
Top 10 Hldgs %
58.26%
Holding
811
New
317
Increased
98
Reduced
90
Closed
269

Top Buys

Rank Stock Value
1
VAL icon
Valaris
VAL
+$24.3M
2
MRNA icon
Moderna
MRNA
+$9.63M
3
SLV icon
iShares Silver Trust
SLV
+$9.23M
4
TMUS icon
T-Mobile US
TMUS
+$9.02M
5
NE icon
Noble Corp
NE
+$6.74M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$107M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$29M
3
APTV icon
Aptiv
APTV
+$22.6M
4
MSFT icon
Microsoft
MSFT
+$20.8M
5
AMZN icon
Amazon
AMZN
+$12.7M

Sector Composition

Rank Sector Weight
1 Healthcare 23.31%
2 Consumer Discretionary 12.31%
3 Materials 12.15%
4 Industrials 5.19%
5 Financials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRL icon
351
Charles River Laboratories
CRL
$12.9B
$333K 0.03%
+1,555
New +$380K
SRG
352
Seritage Growth Properties
SRG
$136M
$332K 0.03%
63,738
+36,331
+133% +$324K
TER icon
353
Teradyne
TER
$57.6B
$332K 0.03%
3,710
+212
+6% +$22.1K
CTIC
354
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$332K 0.03%
55,530
+41,125
+285% +$211K
IRBT
355
DELISTED
iRobot
IRBT
$329K 0.03%
8,953
-5,856
-40% -$283K
ASA
356
ASA Gold and Precious Metals
ASA
$1.09B
$328K 0.03%
+22,361
New +$430K
SBRA icon
357
Sabra Healthcare REIT
SBRA
$5.28B
$327K 0.03%
23,439
-32,534
-58% -$435K
USAK
358
DELISTED
USA Truck Inc
USAK
$327K 0.03%
10,418
-9,626
-48% -$166K
EMR icon
359
Emerson Electric
EMR
$88.7B
$326K 0.03%
+4,101
New +$362K
CMBT
360
CMB.TECH NV
CMBT
$4.7B
$326K 0.03%
+27,333
New +$329K
TEN
361
Tsakos Energy Navigation Ltd
TEN
$1.17B
$324K 0.03%
+36,088
New +$393K
GTX icon
362
Garrett Motion
GTX
$5.48B
$323K 0.03%
+41,781
New +$283K
SRRK icon
363
Scholar Rock
SRRK
$6.24B
$321K 0.03%
+58,443
New +$420K
AMRN
364
Amarin Corp
AMRN
$299M
$320K 0.03%
+10,739
New +$463K
GNK icon
365
Genco Shipping & Trading
GNK
$1.11B
$320K 0.03%
+16,582
New +$374K
AMAT icon
366
Applied Materials
AMAT
$422B
$318K 0.03%
3,497
-1,148
-25% -$126K
FARO
367
DELISTED
Faro Technologies
FARO
$318K 0.03%
10,314
OTIS icon
368
Otis Worldwide
OTIS
$27.7B
$317K 0.03%
4,489
-7,601
-63% -$560K
MU icon
369
Micron Technology
MU
$990B
$316K 0.03%
+5,715
New +$388K
TCDA
370
DELISTED
Tricida, Inc. Common Stock
TCDA
$315K 0.03%
32,519
VRTX icon
371
Vertex Pharmaceuticals
VRTX
$135B
$314K 0.03%
+1,115
New +$298K
BLK icon
372
Blackrock
BLK
$175B
$313K 0.03%
514
-565
-52% -$368K
INTU icon
373
Intuit
INTU
$90.7B
$312K 0.03%
810
-1,873
-70% -$776K
AWR icon
374
American States Water
AWR
$3.42B
$311K 0.03%
3,819
+1,349
+55% +$108K
CCU icon
375
Compañía de Cervecerías Unidas
CCU
$2.21B
$311K 0.03%
+24,601
New +$334K

Similar funds

Caxton Associates (New York)'s Q2 2022 Portfolio in Review

As of Q2 2022, Caxton Associates (New York) held 811 positions worth $1.03B, down 16% from $1.23B the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Caxton Associates (New York)'s Q2 2022 filing shows 317 new, 98 increased, 90 reduced and 269 closed positions. Its largest new stake was Valaris: 451,426 shares worth $19.1M. The largest sale was Tesla, an estimated $107M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Materials.

  • Caxton Associates (New York)'s largest Q2 2022 buy was Valaris: 451,426 shares worth $19.1M.
  • Caxton Associates (New York) added most to Moderna in Q2 2022, an estimated $9.63M increase.
  • Caxton Associates (New York)'s biggest Q2 2022 reduction was Aptiv, cutting an estimated $22.6M.
  • Caxton Associates (New York) fully exited Tesla in Q2 2022, selling an estimated $107M.
  • Caxton Associates (New York)'s ten largest holdings make up 58% of its $1.03B portfolio in Q2 2022.
  • Caxton Associates (New York) opened 317 new positions and closed 269 in Q2 2022.
  • Caxton Associates (New York)'s portfolio value fell 16% quarter-over-quarter to $1.03B.

Based on Caxton Associates (New York)'s 13F filing for Q2 2022, filed 15 Aug 2022.